Inhibition of mitochondrial fission activates glycogen synthesis to support cell survival in colon cancer.

Autor: Hasani S; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA., Young LEA; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA., Van Nort W; College of Agriculture, Food & Environment, University of Kentucky, Lexington, KY, USA., Banerjee M; Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0679, USA., Rivas DR; Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0679, USA., Kim J; Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0679, USA., Xiong X; Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0679, USA., Sun RC; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, USA., Gentry MS; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, USA., Sesaki H; Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gao T; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA. tianyan.gao@uky.edu.; Markey Cancer Center, University of Kentucky, Lexington, KY 40536-0679, USA. tianyan.gao@uky.edu.
Jazyk: angličtina
Zdroj: Cell death & disease [Cell Death Dis] 2023 Oct 10; Vol. 14 (10), pp. 664. Date of Electronic Publication: 2023 Oct 10.
DOI: 10.1038/s41419-023-06202-3
Abstrakt: Metabolic reprogramming has been recognized as one of the major mechanisms that fuel tumor initiation and progression. Our previous studies demonstrate that activation of Drp1 promotes fatty acid oxidation and downstream Wnt signaling. Here we investigate the role of Drp1 in regulating glycogen metabolism in colon cancer. Knockdown of Drp1 decreases mitochondrial respiration without increasing glycolysis. Analysis of cellular metabolites reveals that the levels of glucose-6-phosphate, a precursor for glycogenesis, are significantly elevated whereas pyruvate and other TCA cycle metabolites remain unchanged in Drp1 knockdown cells. Additionally, silencing Drp1 activates AMPK to stimulate the expression glycogen synthase 1 (GYS1) mRNA and promote glycogen storage. Using 3D organoids from Apc f/f /Villin-Cre ERT2 models, we show that glycogen levels are elevated in tumor organoids upon genetic deletion of Drp1. Similarly, increased GYS1 expression and glycogen accumulation are detected in xenograft tumors derived from Drp1 knockdown colon cancer cells. Functionally, increased glycogen storage provides survival advantage to Drp1 knockdown cells. Co-targeting glycogen phosphorylase-mediated glycogenolysis sensitizes Drp1 knockdown cells to chemotherapy drug treatment. Taken together, our results suggest that Drp1-loss activates glucose uptake and glycogenesis as compensative metabolic pathways to promote cell survival. Combined inhibition of glycogen metabolism may enhance the efficacy of chemotherapeutic agents for colon cancer treatment.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: